herpes simplex stomatitis, herpes simplex labialis, orofaryngeale herpes simplex, mucocutane herpes simplex
Advices
Priority | Medication | Remarks |
---|---|---|
Medication: valaciclovir po 500mg 2dd minimum 5 days or
aciclovir iv 5mg/kg 3dd minimum 5 days |
Remarks:
Alleen behandelen bij ernstige infectie |
Priority | Medication | Remarks |
---|---|---|
Medication: valaciclovir po 1000mg 2dd minimum 5 days or
aciclovir iv 5mg/kg 3dd minimum 5 days |
Remarks:
Altijd behandelen |
Sources
-
Pubmed.gov publication # 18541820
Cernik et al., The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008 Jun 9;168(11):1137-44.
-
Pubmed.gov publication # 7036816
Wade et al., Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med. 1982 Mar;96(3):265-9.
-
Pubmed.gov publication # 7048914
Meyers et al., Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. The American Journal of Medicine 1982;73(1A): 229–35.
- https://kennisbank.knmp.nl/
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
External antimicrobial resources
Menu position
Metadata
Swab vid: G-173711.6
Updated: 03/29/2024 - 15:50
Status: Published